30 results
8-K
EX-99.1
OCUL
Ocular Therapeutix Inc
5 Nov 20
Ocular Therapeutix™ Reports Third Quarter 2020 Financial Results and Business Update
4:11pm
for DEXTENZA and OTX-TIC in Select Asian Countries
BEDFORD, Mass. —(BUSINESS WIRE)—November 5, 2020—Ocular Therapeutix™, Inc. (NASDAQ: OCUL … resources to fund its four planned Phase 2 programs.
Announced License Agreement and Collaboration for DEXTENZA and OTX-TIC in Select Asian Countries
8-K
OCUL
Ocular Therapeutix Inc
30 Oct 20
Entry into a Material Definitive Agreement
8:13am
, each a “Field”), in each case in mainland China, Taiwan, Hong Kong, Macau, South Korea, and the countries of the Association of Southeast Asian
424B5
8eatnmihhc6wasp7a
16 Dec 20
Prospectus supplement for primary offering
4:04pm
424B5
idmgp
14 Dec 20
Prospectus supplement for primary offering
5:21pm
424B5
dhmaft6bai
9 Aug 21
Prospectus supplement for primary offering
4:43pm
POSASR
mq3peabnpoj tx1d
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:02pm
POS AM
vgz94gr
28 Feb 22
Prospectus update (post-effective amendment)
5:26pm
S-3ASR
v08m xtubf0i05z950
25 Mar 24
Automatic shelf registration
4:40pm